Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual vs Oral Ticagrelor in ACS
NCT02402400Phase 4Completed
- Sponsor
- Sheba Medical Center
- Start
- Jul 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), non-ST-elevation myocardial infarction (NSTEMI), sponsored by Sheba Medical Center. Started Jul 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT02402400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402400.